Literature DB >> 21501134

Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease.

Waseem Qasim, Sophie Derniame, Kimberly Gilmour, Robert Chiesa, Martin Weber, Stuart Adams, Kanchan Rao, Persis Amrolia, Nicholas Goulden, Paul Veys, Hubert Gaspar.   

Abstract

Mesh：

Year:  2011        PMID： 21501134     DOI： 10.1111/j.1365-2141.2011.08579.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  23 in total

1.  Antiviral cell therapy: is this the future?

Authors:  Juan C Gea-Banacloche
Journal:  Blood       Date:  2013-06-27       Impact factor: 22.113

Review 2.  Adenovirus infections in immunocompetent and immunocompromised patients.

Authors:  Thomas Lion
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 3.  Adoptive immunotherapy with the use of regulatory T cells and virus-specific T cells derived from cord blood.

Authors:  Patrick J Hanley; Catherine M Bollard; Claudio G Brunstein
Journal:  Cytotherapy       Date:  2015-01-24       Impact factor: 5.414

Review 4.  Immunotherapy for transplantation-associated viral infections.

Authors:  Claire Roddie; Karl S Peggs
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

Review 5.  Virus-Specific T Cells: Current and Future Use in Primary Immunodeficiency Disorders.

Authors:  Katherine M Harris; Blachy J Davila; Catherine M Bollard; Michael D Keller
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-21

6.  CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo.

Authors:  Patrick J Hanley; Jan J Melenhorst; Sarah Nikiforow; Phillip Scheinberg; James W Blaney; Gail Demmler-Harrison; C Russell Cruz; Sharon Lam; Robert A Krance; Kathryn S Leung; Caridad A Martinez; Hao Liu; Daniel C Douek; Helen E Heslop; Cliona M Rooney; Elizabeth J Shpall; A John Barrett; John R Rodgers; Catherine M Bollard
Journal:  Sci Transl Med       Date:  2015-04-29       Impact factor: 17.956

Review 7.  Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients.

Authors:  Katherine A Baugh; Ifigeneia Tzannou; Ann M Leen
Journal:  Curr Opin Infect Dis       Date:  2018-08       Impact factor: 4.915

Review 8.  T cells for viral infections after allogeneic hematopoietic stem cell transplant.

Authors:  Catherine M Bollard; Helen E Heslop
Journal:  Blood       Date:  2016-05-20       Impact factor: 22.113

Review 9.  T cell depletion in paediatric stem cell transplantation.

Authors:  C Booth; P Veys
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

10.  "Mini" bank of only 8 donors supplies CMV-directed T cells to diverse recipients.

Authors:  Ifigeneia Tzannou; Ayumi Watanabe; Swati Naik; Rachel Daum; Manik Kuvalekar; Kathryn S Leung; Caridad Martinez; Ghadir Sasa; Mengfen Wu; Adrian P Gee; Robert A Krance; Stephen Gottschalk; Helen E Heslop; Bilal Omer
Journal:  Blood Adv       Date:  2019-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.